🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $PUB.PA and executed a BUY strategy, securing a +9.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$XERS

Xeris Biopharma Holdings Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 06, 2026 ☀️ Open🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP3.55%
MAX GAP RECORD22.59%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY6.4%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL